Elanco Animal Health Incorporated ELAN Stock
Elanco Animal Health Incorporated Price Chart
Elanco Animal Health Incorporated ELAN Financial and Trading Overview
Elanco Animal Health Incorporated stock price | 8.94 USD |
Previous Close | 9.85 USD |
Open | 9.71 USD |
Bid | 7.66 USD x 1300 |
Ask | 10.58 USD x 3100 |
Day's Range | 9.61 - 10.27 USD |
52 Week Range | 7.88 - 20.97 USD |
Volume | 12.13M USD |
Avg. Volume | 8.12M USD |
Market Cap | 5.03B USD |
Beta (5Y Monthly) | 0.92649 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.68 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.21 USD |
ELAN Valuation Measures
Enterprise Value | 10.73B USD |
Trailing P/E | N/A |
Forward P/E | 11.344445 |
PEG Ratio (5 yr expected) | 1.67 |
Price/Sales (ttm) | 1.1321332 |
Price/Book (mrq) | 0.67215276 |
Enterprise Value/Revenue | 2.416 |
Enterprise Value/EBITDA | 10.231 |
Trading Information
Elanco Animal Health Incorporated Stock Price History
Beta (5Y Monthly) | 0.92649 |
52-Week Change | -50.31% |
S&P500 52-Week Change | 20.43% |
52 Week High | 20.97 USD |
52 Week Low | 7.88 USD |
50-Day Moving Average | 9.13 USD |
200-Day Moving Average | 11.6 USD |
ELAN Share Statistics
Avg. Volume (3 month) | 8.12M USD |
Avg. Daily Volume (10-Days) | 6.61M USD |
Shares Outstanding | 492.55M |
Float | 490.47M |
Short Ratio | 1.01 |
% Held by Insiders | 0.52% |
% Held by Institutions | 100.29% |
Shares Short | 8.9M |
Short % of Float | 2.19% |
Short % of Shares Outstanding | 1.80% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -0.58% |
Operating Margin (ttm) | 9.79% |
Gross Margin | 57.27% |
EBITDA Margin | 23.61% |
Management Effectiveness
Return on Assets (ttm) | 1.69% |
Return on Equity (ttm) | -0.34% |
Income Statement
Revenue (ttm) | 4.44B USD |
Revenue Per Share (ttm) | 9.08 USD |
Quarterly Revenue Growth (yoy) | 2.50% |
Gross Profit (ttm) | 2.5B USD |
EBITDA | 1.05B USD |
Net Income Avi to Common (ttm) | -26000000 USD |
Diluted EPS (ttm) | -0.05 |
Quarterly Earnings Growth (yoy) | 102.00% |
Balance Sheet
Total Cash (mrq) | 326M USD |
Total Cash Per Share (mrq) | 0.66 USD |
Total Debt (mrq) | 6.03B USD |
Total Debt/Equity (mrq) | 80.6 USD |
Current Ratio (mrq) | 2.248 |
Book Value Per Share (mrq) | 15.19 |
Cash Flow Statement
Operating Cash Flow (ttm) | 369M USD |
Levered Free Cash Flow (ttm) | 224.75M USD |
Profile of Elanco Animal Health Incorporated
Country | United States |
State | IN |
City | Greenfield |
Address | 2500 Innovation Way |
ZIP | 46140 |
Phone | 877 352 6261 |
Website | https://www.elanco.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 9000 |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield, Indiana.
Q&A For Elanco Animal Health Incorporated Stock
What is a current ELAN stock price?
Elanco Animal Health Incorporated ELAN stock price today per share is 8.94 USD.
How to purchase Elanco Animal Health Incorporated stock?
You can buy ELAN shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Elanco Animal Health Incorporated?
The stock symbol or ticker of Elanco Animal Health Incorporated is ELAN.
Which industry does the Elanco Animal Health Incorporated company belong to?
The Elanco Animal Health Incorporated industry is Drug Manufacturers-Specialty & Generic.
How many shares does Elanco Animal Health Incorporated have in circulation?
The max supply of Elanco Animal Health Incorporated shares is 496.46M.
What is Elanco Animal Health Incorporated Price to Earnings Ratio (PE Ratio)?
Elanco Animal Health Incorporated PE Ratio is 13.14705850 now.
What was Elanco Animal Health Incorporated earnings per share over the trailing 12 months (TTM)?
Elanco Animal Health Incorporated EPS is 0.68 USD over the trailing 12 months.
Which sector does the Elanco Animal Health Incorporated company belong to?
The Elanco Animal Health Incorporated sector is Healthcare.
Elanco Animal Health Incorporated ELAN included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE COMPOSITE (DJ) NYA | 17438.64 USD — |
-1.02
|
— — | — — | — — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
Nasdaq US Smart Pharmaceuticals NQSSPH | 1314.87 USD — |
-1.21
|
— — | 1267.2 USD — | 1347.29 USD — | — - | — — |
- {{ link.label }} {{link}}